The DeciBio team interviews Colossal Biosciences’ co-founder and CEO, Ben Lamm and Colossal Biosciences' Scientific Advisor and Professor of Computational Genomics, Christopher Mason, to discuss the science behind Colossal's mission to de-extinct the woolly mammoth and furthermore, the implications their advancements in genetic engineering and embryology, may have on human health applications.
All content for The DeciBiome is the property of DeciBio and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The DeciBio team interviews Colossal Biosciences’ co-founder and CEO, Ben Lamm and Colossal Biosciences' Scientific Advisor and Professor of Computational Genomics, Christopher Mason, to discuss the science behind Colossal's mission to de-extinct the woolly mammoth and furthermore, the implications their advancements in genetic engineering and embryology, may have on human health applications.
Accelerating Precision Medicine Through Biomarker Testing: A DeciBio Expert Panel Discussion
The DeciBiome
38 minutes
2 years ago
Accelerating Precision Medicine Through Biomarker Testing: A DeciBio Expert Panel Discussion
How do you maximize clinical trial samples, especially as we face a growing need for biomarker testing? Learn more about these precision medicine questions as one of our experts interviews a panel of leaders from pharma, clinical testing, and hospital settings.
The DeciBiome
The DeciBio team interviews Colossal Biosciences’ co-founder and CEO, Ben Lamm and Colossal Biosciences' Scientific Advisor and Professor of Computational Genomics, Christopher Mason, to discuss the science behind Colossal's mission to de-extinct the woolly mammoth and furthermore, the implications their advancements in genetic engineering and embryology, may have on human health applications.
